Sun-Young Han

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 5

Top Topics

Top Venues

Pharmaceuticals (Basel, Switzerland)

Investigational new drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Sun-Young Han
Small Molecule Induced FLT3 Degradation. Pharmaceuticals (Basel, Switzerland) 15 (3) (2022)
Md Entaz Bahar, Sun-Young Han, Ji-Ye Kim, Hyonok Yoon
Chemotherapy Resistance: Role of Mitochondrial and Autophagic Components. Cancers 14 (6) (2022)
Sun-Young Han
TRK Inhibitors: Tissue-Agnostic Anti-Cancer Drugs. Pharmaceuticals (Basel, Switzerland) 14 (7) (2021)
Hyo Jeong Lee, Pyeonghwa Jeong, Yeongyu Moon, Jungil Choi, Jeong Doo Heo, Yong-Chul Kim, Sun-Young Han
Characterization of LDD-2633 as a Novel RET Kinase Inhibitor with Anti-Tumor Effects in Thyroid Cancer. Pharmaceuticals (Basel, Switzerland) 14 (1) (2021)
Hyo Jeong Lee, Bo-Kyoung Kim, Kyoung Bin Yoon, Yong-Chul Kim, Sun-Young Han
Novel inhibitors of lysine (K)-specific Demethylase 4A with anticancer activity. Investigational new drugs 35 (6) (2017)